Mirogabalin besylate is a gabapentinoid anticonvulsant medication primarily indicated for the treatment of pain associated with fibromyalgia, diabetic peripheral neuropathy, and post-herpetic neuralgia.… Read more
Mirogabalin besylate is a gabapentinoid anticonvulsant medication primarily indicated for the treatment of pain associated with fibromyalgia, diabetic peripheral neuropathy, and post-herpetic neuralgia. Analytical laboratories utilize high-quality reference standards of this compound, including its racemic form and stable isotope labelled versions, to ensure precise measurement and regulatory compliance during drug development. These materials are essential for rigorous impurity profiling, method validation, and quantitative analysis, enabling researchers to accurately identify and quantify the active pharmaceutical ingredient alongside potential degradation products or synthesis-related impurities. By employing deuterium-labelled internal standards, scientists can achieve greater accuracy in mass spectrometry assays and pharmacokinetic studies. This comprehensive selection of analytical tools supports the development and quality control of pharmaceutical formulations throughout the product lifecycle.